Medical Articles 5/17
Posted by rob on May 17, 2008 under Uncategorized | 
Be the First to Comment
A Worldwide Support Network For Chronic Myelogenous Leukemia
Archives
- March 2013
- February 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- May 2012
- March 2012
- February 2012
- January 2012
- October 2011
- September 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005
- June 2005
- May 2005
- April 2005
- March 2005
- February 2005
- January 2005
- December 2004
- November 2004
- October 2004
- September 2004
- August 2004
- July 2004
- June 2004
Recent Posts
- A New Case of dic(1;15)(p11;p11) in AML M1: Apropos of a Case and a Review of the Literature.
- Monitoring M-BCR-ABL expression level in CML patients by RQ-PCR: experience of a single Center.
- Clinical characteristics and the usefulness of the QuantiFERON-TB Gold In-Tube test in hematologic patients with hepatic or splenic lesions.
- Measurement of imatinib uptake by flow cytometry.
- Effects of the hedgehog inhibitor GDC-0449, alone or in combination with dasatinib, on BCR-ABL-positive leukemia cells.
- Bortezomib and Vorinostat in Refractory Acute Myelogenous Leukemia and High Risk Myelodysplastic Syndromes: Produces Stable Disease but at the Cost of High Toxicity.
- Significant weight gain in patients with chronic myeloid leukemia after imatinib therapy.
- Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors.
- SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
- Chronic myelogenous leukemia.
- Predictors of Neuropsychological Change in Patients with Chronic Myelogenous Leukemia and Myelodysplastic Syndrome.
- [Inhibitory effects of rapamycin on proliferation of chronic myelogenous leukemia cells and its mechanism].
- MiR-24 Promotes the Survival of Hematopoietic Cells.
- Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease.
- Activation of c-Jun N-Terminal Kinase Mediates Tanshinone IIA-Induced Apoptosis in KBM-5 Chronic Myeloid Leukemia Cells.